A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2021.06.007
Abstract: Highlights • Dose escalation with IMRT to 60 Gy for esophageal cancer is feasible.• Dose escalation with cisplatin/5-FU still results in significant toxicity.• Improved local control, but comparable survival compared to historical controls.• Pretreatment weight… read more here.
Keywords: esophageal; dose escalation; study; phase feasibility ... See more keywords
CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Sign Up to like & getrecommendations! Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae064.050
Abstract: Abstract BACKGROUND Adamantinomatous craniopharyngioma (ACP) is a devastating skull-base tumor believed to derive from epithelial remnants of the primordial craniopharyngeal duct (Rathke’s pouch), which gives rise to the anterior pituitary gland. ACP lacks medical antitumor… read more here.
Keywords: adamantinomatous craniopharyngioma; trial; tocilizumab; phase feasibility ... See more keywords